← New search
Phenotype profile

hepatocellular carcinoma

SaudiVarKB evidence summary derived from retained literature mentions.

298Phenotype mentions
100Publications
50Associated gene records
50Associated variant records

Associated gene records

Co-mentioned in the same publications
GeneIdentifier / contextArticlesMentions
STAT3HGNC:1136499
TP53HGNC:1199888
AFPHGNC:31777
BCL2HGNC:99066
BAXHGNC:95966
EGFRHGNC:323644
TLR4HGNC:1185044
MMP9HGNC:717644
MYCHGNC:755344
AURKAHGNC:1139344
CD4HGNC:167833
CTNNB1HGNC:251433
JAK2HGNC:619233
TLR3HGNC:1184933
SMAD4HGNC:677033
RB1HGNC:988433
CASP3HGNC:150433
CENPFHGNC:185733
NCAPGHGNC:2430433
PNPLA3HGNC:1859033
MICAHGNC:709033
TNFHGNC:1189222
GLI1HGNC:431722
PTENHGNC:958822
LDLRHGNC:654722
CYP3A4HGNC:263722
AKT1HGNC:39122
VDRHGNC:1267922
HFEHGNC:488622
RRM2HGNC:1045222
PIK3CAHGNC:897522
CD44HGNC:168122
JAK1HGNC:619022
APOBHGNC:60322
HSP90AA1HGNC:525322
TPMTHGNC:1201422
MCM2HGNC:694422
CEP55HGNC:116122
HOTAIRHGNC:3351022
CCNB1HGNC:157922
MAPK3HGNC:687722
ERBB2HGNC:343022
TOP2AHGNC:1198922
PRKCGHGNC:940222
NFE2L2HGNC:778222
DEPDC5HGNC:1842322
PARP1HGNC:27011
PAHHGNC:858211
COL1A1HGNC:219711
MCM4HGNC:694711

Associated variant records

Co-mentioned in the same publications
VariantIdentifier / contextArticlesMentions
rs1331262028rs133126202822
rs2596542rs259654222
rs5743314rs574331422
rs2856718rs285671822
rs9275572rs927557222
rs7453920rs745392022
rs6505162rs650516211
rs1544410rs154441011
rs11614913rs1161491311
rs731236rs73123611
p.W577Cp.W577C11
p.H166Rp.H166R11
G894TG894T11
rs2228570rs222857011
rs231775rs23177511
rs7975232rs797523211
rs14095rs1409511
rs114416617rs11441661711
rs145795985rs14579598511
rs1951964rs195196411
rs45582331rs4558233111
rs44582331rs4458233111
rs3742305rs374230511
rs361525rs36152511
N103DN103D11
Q30KQ30K11
I208TI208T11
rs378117rs37811711
rs1329774rs132977411
rs4745058rs474505811
rs2427043rs242704311
rs76228864rs7622886411
rs76754767rs7675476711
rs45593131rs4559313111
rs2792999rs279299911
rs8038528rs803852811
rs1998853rs199885311
rs12440990rs1244099011
rs4774596rs477459611
rs3787728rs378772811
rs1005695rs100569511
rs2243250rs224325011
rs1800795rs180079511
rs1162102190rs116210219011
rs868127012rs86812701211
rs750830348rs75083034811
rs768619375rs76861937511
rs752329416rs75232941611
rs2910164rs291016411
rs1199520604rs119952060411

Associated population records

Co-mentioned in the same publications
PopulationIdentifier / contextArticlesMentions
Saudi Arabia99
Population recordCohort 10044
Population recordCohort 433
Population recordCohort 2022
Population recordCohort 022
Population recordCohort 222
Population recordCohort 522
Saudi ArabiaCohort 4022
Saudi ArabiaCohort 58422
Population recordCohort 26411
Population recordCohort 1111
Saudi ArabiaCohort 45011
Population recordCohort 111
Population recordCohort 8211
Population recordCohort 5011
Population recordCohort 5611
Population recordCohort 19411
Population recordCohort 6211
Saudi ArabiaCohort 1311
Population recordCohort 13411
Population recordCohort 12011
Population recordCohort 7011
Saudi Arabia · Asir11
Population recordCohort 21011
Saudi ArabiaCohort 3211
Population recordCohort 34811
Saudi Arabia · HailCohort 111
Population recordCohort 15011
Population recordCohort 4111
Population recordCohort 12211
Saudi ArabiaCohort 111
Population recordCohort 12411
Population recordCohort 34911
Saudi ArabiaCohort 5711
Saudi ArabiaCohort 9511
Population recordCohort 24011
Population recordCohort 12611
Saudi ArabiaCohort 411
Saudi ArabiaCohort 18211
Saudi ArabiaCohort 20011
Population recordCohort 13611
Population recordCohort 56711
Population recordCohort 7811
Saudi Arabia · JeddahCohort 811
Population recordCohort 10711
Population recordCohort 71311
Population recordCohort 23711
Population recordCohort 2,50011
Population recordCohort 30011
Saudi Arabia · Medina11

Supporting publications

100 records
  1. 2026Phytochemical Profiling and Anticancer Potential of Fagonia cretica L. Extracts on Liver Cancer (HepG2) Cells using In vitro and In silico Approaches.Anti-cancer agents in medicinal chemistry1 mentions
  2. 2026Citrate-capped AuNPs-induced redox reprogramming modulates the TP53-BAX/BCL2-CASP3 Axis, reinforcing antioxidant defense and promoting apoptotic signaling in liver Cancer.Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy1 mentions
  3. 2026Bacterial-extract mediated gold nanoparticles: Enhanced uptake, oxidative stress, and cytotoxicity in HepG2 cells with biofilm inhibition and antibiotic synergy.Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy1 mentions
  4. 2026In silico identification of a prognostic gene signature and virtual screening for hepatocellular carcinoma.Computational biology and chemistry1 mentions
  5. 2026Intermittent fasting and liver disease: Insights from the Ramadan model.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association1 mentions
  6. 2026Nanoparticle-based approaches for doxorubicin delivery in hepatocellular carcinoma: Current strategies and emerging innovations.Seminars in oncology1 mentions
  7. 2026MicroRNA-mediated metabolic control in HCC: From molecular networks to therapy.Experimental cell research1 mentions
  8. 2026Integrative analysis of tissue and circulating miRNAs as biomarkers for progression and survival in hepatocellular carcinoma.Non-coding RNA research1 mentions
  9. 2026Unraveling risk factors and transcriptomic signatures in liver cancer progression and mortality through machine learning and bioinformatics.Briefings in functional genomics1 mentions
  10. 2026Association between elevated PRIM1 expression and poor prognosis in human urothelial carcinoma.Journal of Taibah University Medical Sciences1 mentions
  11. 2026Clinical biomarkers and biosensors for early detection of metabolic dysfunction-associated steatohepatitis (MASH): a translational perspective.Frontiers in bioengineering and biotechnology1 mentions
  12. 2026Carriage of rare APOB variants predisposes to severe steatotic liver disease and hepatocellular carcinoma.The Journal of clinical investigation1 mentions
  13. 2026Genetic insights into hepatocellular carcinoma: the role of VDR FokI (rs2228570) and TaqI (rs731236) polymorphisms in Egyptian patients.BMC medical genomics1 mentions
  14. 2026Comprehensive multi-omics analysis reveals RUNX1's prognostic value, immune associations, and MUC13-Mediated mechanistic role in hepatocellular carcinoma pathogenesis.Biochemistry and biophysics reports1 mentions
  15. 2026Identification of potential key genes and molecular mechanisms of oral squamous cell carcinoma based on integrated bioinformatics approach.Journal, genetic engineering & biotechnology1 mentions
  16. 2026Engineering CAR-based cellular immunotherapy for hepatocellular carcinoma: Current barriers, innovative strategies, and future directions.Critical reviews in oncology/hematology1 mentions
  17. 2026Single-Cell Transcriptomic Integration Identifies LTA4H as an Immune-Associated Therapeutic Target in Hepatocellular Carcinoma.Cell biochemistry and biophysics1 mentions
  18. 2026FedLiverNet: a federated learning framework for privacy-preserving and efficient liver cancer detection.Scientific reports1 mentions
  19. 2026Beyond silencing: integrative multi-omics and spatial profiling unravel the systems-level role of piRNAs in HBV-driven Hepatocarcinogenesis.Molecular biology reports1 mentions
  20. 2026Liver transplantation for Wilson disease: a spectrum from acute liver failure to Neuro-Wilson.BMC gastroenterology1 mentions
  21. 2026Breaking the serologic rule: chronic hepatitis B with simultaneous HBsAg and anti-HBs positivity-a case report.Journal of medical case reports1 mentions
  22. 2026Green synthesis of Ginkgo biloba-mediated magnetite (Fe3O4) nanoparticles: multifunctional antimicrobial, anticancer, and antioxidant activities with molecular mechanistic insights.Bioprocess and biosystems engineering1 mentions
  23. 2026Development and Characterization of PEGylated β-Carotene-Loaded Liposomes as Radiosensitizers in HepG2 Hepatocellular Carcinoma Cells: In Vitro and In Silico Studies.Anti-cancer agents in medicinal chemistry1 mentions
  24. 2026AI in multi-omics analysis of liver diseases.Progress in molecular biology and translational science1 mentions
  25. 2026Uncovering Prognostic Biomarkers Underlying Hepatocellular Carcinoma Through Integrative Multi-Omics and a Network-Based Approach.International journal of molecular sciences1 mentions
  26. 2026Hepatitis B virus-induced hepatocellular carcinoma: HBx-associated epigenetic mechanisms and therapeutic opportunities.Cancer gene therapy1 mentions
  27. 2026Peri-transplant use of immune checkpoint inhibitors in hepatocellular carcinoma: a transplant oncology perspective on safety, timing, post-transplant management, and future directions.Frontiers in oncology1 mentions
  28. 2026Novel Monoazo Dispersion Dyes Incorporating a 4-thiazolidinone Moiety: Synthesis, Structural Characterization, Molecular Docking, and Anticancer Investigations.Current medicinal chemistry1 mentions
  29. 2026Synthesis and multilevel evaluation of benzimidazole-based anticancer compounds: DNA/serum albumin interaction, and in-depth theoretical insights.Molecular and cellular biochemistry1 mentions
  30. 2025A Saffron-based Polyherbal Formulation DuK Prevents Hepatocellular Carcinoma in Male Wistar Rats.Current cancer drug targets1 mentions
  31. 2025Network-base approaches to identify therapeutic biomarkers in hepatocellular carcinoma and search for drug hunting utilizing molecular dynamics simulations.Journal of biomolecular structure & dynamics1 mentions
  32. 2025MicroRNA as Key Players in Hepatocellular Carcinoma: Insights into Their Role in Metastasis.Biochemical genetics1 mentions
  33. 2025Phosphoinositide 3-Kinase Inhibitors from Gladiolus Segetum Ker-Gawl Corms Supported by Network Pharmacology.Chemistry & biodiversity1 mentions
  34. 2025FGF21 affects the glycolysis process via mTOR-HIF1α axis in hepatocellular carcinoma.Cellular signalling1 mentions
  35. 2025Current advances in nanoparticle-based approaches for the hepatocellular carcinoma treatment.Clinics and research in hepatology and gastroenterology1 mentions
  36. 2025Pathological roles of lncRNA HOTAIR in liver cancer: An updated review.Gene1 mentions
  37. 2025A Comprehensive Review Highlighting the Prospects of Phytonutrient Berberine as an Anticancer Agent.Journal of biochemical and molecular toxicology1 mentions
  38. 2025Aloe arborescens Standardized Glycosidic Fraction Suppresses Hepatocarcinoma by Modulating TIMP1, MMP9 Genes Expression, and Inflammation/Ki67/TGFβ1 Pathway.Phytotherapy research : PTR1 mentions
  39. 2025Personalized treatment approaches in hepatocellular carcinoma.Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology1 mentions
  40. 2025HCV and HBV genotypes: vital in the progression of HCV/ HBV co-infection.BMC gastroenterology1 mentions
  41. 2025Insights into the cytotoxicity of photoactivatable Ru(II) carbonyl complexes towards human liver carcinoma cells.Bioorganic chemistry1 mentions
  42. 2025Unveiling NLR pathway signatures: EP300 and CPN60 markers integrated with clinical data and machine learning for precision NASH diagnosis.Cytokine1 mentions
  43. 2025Novel triazoloquinazoline derivatives as VEGFR inhibitors: synthesis, cytotoxic evaluation and in silico studies.Future medicinal chemistry1 mentions
  44. 2025Antimicrobial and cytotoxic activities of natural (Z)-13-docosenamide derived from Penicillium chrysogenum.Frontiers in cellular and infection microbiology1 mentions
  45. 2025The role of Prolyl 3-Hydroxylase 1 (P3H1) in tumor development and prognosis: a pan-cancer analysis with validation in colonic adenocarcinoma.American journal of translational research1 mentions
  46. 2025Sirtuins and Gut Microbiota: Dynamics in Health and a Journey from Metabolic Dysfunction to Hepatocellular Carcinoma.Cells1 mentions
  47. 2025Differentially expressed and alternately spliced genes as a novel tool for genotoxicity: a computerized study in ATT-myc transgenic mice for the recognition of genotoxic and non-genotoxic chemical.Frontiers in genetics1 mentions
  48. 2025Therapeutic potential of Bacopa monnieri extracts against hepatocellular carcinoma through in-vitro and computational studies.PloS one1 mentions
  49. 2025Chronic active and chronic inactive hepatitis B virus infection: Comparative study of genetic polymorphism and blood profile measures.PloS one1 mentions
  50. 2025Anthocyanins: From Natural Colorants to Potent Anticancer Agents.Food science & nutrition1 mentions
  51. 2025Deciphering cGAS-STING signaling: implications for tumor immunity and hepatocellular carcinoma.Naunyn-Schmiedeberg's archives of pharmacology1 mentions
  52. 2025Hepatobiliary Cancers in Saudi Arabia From 2000 to 2025.Cureus1 mentions
  53. 2025Enhancing hepatocellular carcinoma treatment: synergistic cytotoxicity and mechanistic insights of Ramucirumab and 5-Azacytidine combination therapy.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society1 mentions
  54. 2025The Influence of CYP2B6, GSTP1, and SLCO1B1 Star Allele-Predicted Phenotypes and CBR1 Genetic Variants on Effectiveness Outcomes in Patients With Hepatocellular Carcinoma Receiving Doxorubicin via Transarterial Chemoembolization.Pharmacology research & perspectives1 mentions
  55. 2025In vivo and in vitro therapeutic evaluation of bone marrow-derived mesenchymal stem cells in liver cancer treatment.Frontiers in cell and developmental biology1 mentions
  56. 2025Preliminary Evaluation of Plasma circ_0009910, circ_0027478, and miR-1236-3p as Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma.International journal of molecular sciences1 mentions
  57. 2025Anticancer Effects of Monacolin X Against Human Liver Cancer Cell Line: Exploring the Apoptosis Using AO/EB and DCFHDA Fluorescent Staining.Luminescence : the journal of biological and chemical luminescence1 mentions
  58. 2025Imiquimod-Loaded Phospholipid-Free Small Unilamellar Vesicles Activate the Tumor Immune Microenvironment to Treat Liver Cancer and Liver Metastases.Advanced healthcare materials1 mentions
  59. 2025Genetic polymorphisms as predictors of the response of hepatocellular carcinoma patients to doxorubicin chemotherapy: a genome-wide association study.Frontiers in pharmacology1 mentions
  60. 2025Mutational landscape of the surface antigen of hepatitis B virus in patients with hepatocellular carcinoma.Gut pathogens1 mentions
  61. 2025Endophytic Trichoderma asperellum WNZ-21 produces novel bioactives with anticancer, anti-inflammatory, and hemoprotective properties from fermented bean biomass.Frontiers in microbiology1 mentions
  62. 2025Non-coding RNAs as key regulators in hepatitis B virus-related hepatocellular carcinoma.Frontiers in immunology1 mentions
  63. 2025Role of Liquid Biopsy for Early Detection, Prognosis, and Therapeutic Monitoring of Hepatocellular Carcinoma.Diagnostics (Basel, Switzerland)1 mentions
  64. 2025A Comprehensive Review on the Molecular Mechanism of Lycopene in Cancer Therapy.Food science & nutrition1 mentions
  65. 2025Shallow whole-genome sequencing of circulating tumour DNA predicts clinical outcomes to systemic therapy in advanced hepatocellular carcinoma.European journal of cancer (Oxford, England : 1990)1 mentions
  66. 2025Revolutionizing cancer treatment with Halomonas Aquamarina L-Glutaminase: insights from in vitro and computational studies.Scientific reports1 mentions
  67. 2025Pan-cancer analysis of PTPN6: prognostic significance and functional implications in tumor progression.Discover oncology1 mentions
  68. 2025Reprogramming the hepatic immune microenvironment with mirtazapine in early neoplastic transformation: Evidence from a diethylnitrosamine-induced rat model.Chemico-biological interactions1 mentions
  69. 2025Resveratrol Alleviates Aflatoxin B1-induced Renal Cortex Oxidative Stress and Apoptosis in Adult Male Albino Rats.International journal of applied & basic medical research1 mentions
  70. 2025Green algae-derived sulfated polysaccharide-capped AgNPs with Decanoic and 9-Octadecenoic acid derivatives induce cytotoxicity via PI3Kα/mTOR pathway in HepG2 cell line.International journal of biological macromolecules1 mentions
  71. 2025Folate- and chitosan-functionalized lipid nanoparticles for co-delivery of pioglitazone and simvastatin to enhance hepatic cancer therapy: effects on IL-1β, IL-6, BCL2/BAX gene expression, and GPX4, COX-2, and MMP-9 activities.Molecular biology reports1 mentions
  72. 2025Estimating high mobility group box protein 1 (HMGB1) single nucleotide polymorphisms among hepatitis B virus infected patients of Pakistan origin.Brazilian journal of biology = Revista brasleira de biologia1 mentions
  73. 2025DC09, Derivative of 3-(2-hydroxy-5-methoxyphenyl)-1-(5-methylfuran-2-yl)prop-2-en-1-one Attenuates Nonalcoholic Fatty Liver Disease by Targeting PI3K/Akt Pathway: Insights From In-Vivo Zebrafish Model and In-Vitro HepG2 Cell.Journal of biochemical and molecular toxicology1 mentions
  74. 2025Oncogenic EME1 promotes tumor progression and immune modulation in human cancers with therapeutic targeting potential.Discover oncology1 mentions
  75. 2025Selective Angiographic Roadmap Analysis (SARA) of Hepatocellular Carcinoma Feeding Arteries for Transarterial Chemoembolization.Diagnostics (Basel, Switzerland)1 mentions
  76. 2025Investigating the Roles of MAPKs as Precision Oncology Targets: A Multi-cancer Expression and Survival Study.Cancer genomics & proteomics1 mentions
  77. 2025Budd-Chiari syndrome: Prognostic scores, special populations, and management challenges.World journal of gastroenterology1 mentions
  78. 2025ASK1 Signaling in Cancer: Pathogenic Driver or Therapeutic Target?Journal of biochemical and molecular toxicology1 mentions
  79. 2025Proton beam therapy indications in the Kingdom of Saudi Arabia: A SARO clinical practice guideline.Saudi medical journal1 mentions
  80. 2025Investigating the pathogenic potential of PKC-eta UTR variants in cancer progression.Computers in biology and medicine1 mentions
  81. 2025Association of vitamin D receptor gene polymorphisms ApaI (rs7975232) and BsmI (rs1544410) with hepatocellular carcinoma susceptibility in Egyptian patients.Molecular biology reports1 mentions
  82. 2024Utility of a microRNA panel in diagnosis and prognosis of hepatitis C-associated hepatocellular carcinoma.Laboratory medicine1 mentions
  83. 2024Leonurine ameliorates the STAT3 pathway through the upregulation of SHP-1 to retard the growth of hepatocellular carcinoma cells.Cellular signalling1 mentions
  84. 2024Itraconazole halts hepatocellular carcinoma progression by modulating sonic hedgehog signaling in rats: A novel therapeutic approach.Pathology, research and practice1 mentions
  85. 2024Extracellular vesicles as tools and targets in therapy for diseases.Signal transduction and targeted therapy1 mentions
  86. 2024The role of TAOK3 in cancer progression and development as a prognostic marker: A pan-cancer analysis study.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society1 mentions
  87. 2024Unlocking the diagnostic, prognostic roles, and immune implications of BAX gene expression in pan-cancer analysis.American journal of translational research1 mentions
  88. 2024Harnessing the supremacy of MEG3 LncRNA to defeat gastrointestinal malignancies.Pathology, research and practice1 mentions
  89. 2024Echinacoside ameliorates hepatic fibrosis and tumor invasion in rats with thioacetamide-induced hepatocellular carcinoma.Biomolecules & biomedicine1 mentions
  90. 2024Multi-objective liver cancer algorithm: A novel algorithm for solving engineering design problems.Heliyon1 mentions
  91. 2024c-MET pathway in human malignancies and its targeting by natural compounds for cancer therapy.Phytomedicine : international journal of phytotherapy and phytopharmacology1 mentions
  92. 2024Thorough examination of the potential biological implications of the cuproptosis-related gene LIPT2 in the prognosis and immunotherapy in pan-cancer.American journal of translational research1 mentions
  93. 2024Decoding the DSCC1 gene as a pan-cancer biomarker in human cancers via comprehensive multi-omics analyses.American journal of translational research1 mentions
  94. 2024In silico design of a novel multi-epitope vaccine against HCV infection through immunoinformatics approaches.International journal of biological macromolecules1 mentions
  95. 2024RETRACTED: Potential Antitumor Activity of Combined Lycopene and Sorafenib against Solid Ehrlich Carcinoma via Targeting Autophagy and Apoptosis and Suppressing Proliferation.Pharmaceuticals (Basel, Switzerland)1 mentions
  96. 2024Non-coding RNA mediated regulation of PI3K/Akt pathway in hepatocellular carcinoma: Therapeutic perspectives.Pathology, research and practice1 mentions
  97. 2024Determination of hepatitis C virus subtype prevalent in Sindh, Pakistan: a phylogenetic analysis.Scientific reports1 mentions
  98. 2024Biosensing of Alpha-Fetoprotein: A Key Direction toward the Early Detection and Management of Hepatocellular Carcinoma.Biosensors1 mentions
  99. 2024Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation Analysis Reveal Insights into the Molecular Mechanism of Cordia myxa in the Treatment of Liver Cancer.Biology1 mentions
  100. 2024MAFLD: an ideal framework for understanding disease phenotype in individuals of normal weight.Therapeutic advances in endocrinology and metabolism1 mentions